Skip to content

Hyperthyroidism: Pathology review

Videos

Notes

Pathology

Endocrine system

Adrenal gland disorders
Thyroid gland disorders
Parathyroid gland disorders
Pancreatic disorders
Pituitary gland disorders
Gonadal dysfunction
Polyglandular syndromes
Endocrine tumors
Endocrine system pathology review

Assessments
Hyperthyroidism: Pathology review

Questions

1 / 10 complete
Questions

USMLE® Step 1 style questions USMLE

10 questions
Preview

A 30-year-old primigravida woman comes to the clinic at 10 weeks gestation due to flu-like symptoms and low grade fever. A few weeks ago, she visited the clinic due to insomnia, anxiety, and palpitations. After a diagnosis was made, she was initiated with the appropriate treatment. Current temperature is 37.8°C (100.0°F), pulse is 80/min, and blood pressure is 132/83 mmHg. On physical examination, pharyngitis without exudate is noted. The absolute neutrophil count is 800/microL. Which of the following medications was most likely prescribed?

Transcript

Content Reviewers:

Yifan Xiao, MD

On the Endocrinology ward, two individuals came in.

The first one is 55 year old Gregor, who came in complaining about weight loss, heat intolerance, chest pain, palpitations and insomnia.

On the clinical examination, he’s anxious and restless.

He had warm and moist skin, his eyelids were retracted and there was exophthalmos of both eyes and tachycardia.

The other person is 37 year old Josie who migrated to the US from Panama.

She came in with similar symptoms as Gregor but on clinical examination, she also had a goiter.

According to her, she recently had a contrast imaging procedure for a different problem.

TSH and levels of T3 and T4 were taken for both individuals.

Levels of TSH were low, while levels of T3 and T4 were high.

Okay, so both individuals had hyperthyroidism.

First, a bit of physiology.

Normally, the hypothalamus detects low blood levels of thyroid hormones and releases thyrotropin-releasing hormone, or TRH, into the hypophyseal portal system.

The anterior pituitary then releases thyroid-stimulating hormone, also called thyrotropin, or simply TSH.

TSH stimulates the thyroid gland which is a gland located in the neck.

The thyroid gland is made up of thousands of follicles, which are small spheres lined with follicular cells.

Follicular cells convert thyroglobulin, a protein found in follicles, into two iodine-containing hormones, triiodothyronine or T3, and thyroxine or T4.

Once released from the thyroid gland, these hormones enter the blood and bind to circulating plasma proteins.

Only a small amount of T3 and T4 will travel unbound in the blood, and these two hormones get picked up by nearly every cell in the body.

Once inside the cell T­4 is mostly converted into T3, and it can exert its effect. T3 speeds up the cell’s basal metabolic rate.

T3 increases cardiac output, stimulates bone resorption, thinning out the bones, and activates the sympathetic nervous system.

Thyroid hormones are also involved in a number of other things, like controlling sebaceous and sweat gland secretion, hair follicle growth, and regulating proteins and mucopolysaccharide synthesis by skin fibroblasts.

Now hyperthyroidism can happen a few different ways and all of them result in too much thyroid hormone and a hypermetabolic state, where cellular reactions are happening faster than normal.

First, hyperthyroidism can be primary, in which case the thyroid gland is the problem and it’s making too many hormones.

There are a few specific diseases associated only with hyperthyroidism but sometimes diseases like thyroiditis, which damages the thyroid and causes hypothyroidism, can cause stored thyroid hormones to leak out, resulting in an initial period of transient hyperthyroidism.

Then there’s secondary hyperthyroidism, where the problem is increased TSH secretion due to a problem with the pituitary gland, like a rare TSH secreting adenoma.

Now, let’s talk about some of the causes of primary hyperthyroidism.

Graves disease is the most common cause of hyperthyroidism, which can sometimes manifests during periods of stress, like during pregnancy.

This is an autoimmune disorder where B cells produce antibodies against several thyroid proteins.

The most high yield autoantibodies you need to remember is thyroid-stimulating immunoglobulins, which are type G immunoglobulins that produce a type II hypersensitivity reaction.

They bind to the TSH receptor on follicular cells and imitate TSH. This results in growth of the thyroid gland and stimulates the follicular cells to produce excess thyroid hormone.

Now, these autoantibodies can also cause Graves ophthalmopathy.

These antibodies activate the T-cells in the retro-orbital space causing them to secrete cytokines like TNF-alpha and IFN-gamma which increase fibroblast secretion of glycosaminoglycans which ultimately increase muscle swelling, muscle inflammation and increase the number of adipocyte count, leading to exophthalmos, which is anterior bulging of the eyes.

Now, thyroid stimulating immunoglobulins also increase the activity of dermal fibroblasts, resulting in pretibial myxedema, with the classical finding of waxy lesions with non-pitting edema that usually appear first on the lower legs.

Now, there is a gene complex involved in the regulation of the immune response and this is called the human leukocyte antigen system, or HLA system.

Interestingly, individuals with Graves disease often have specific HLA genes such as HLA-DR3 and HLA-B8, which are important clues on your exams.

Histology of the thyroid will show tall and crowded follicular epithelial cells with scalloped colloid.

Another cause is toxic multinodular goiter where one or more follicles starts growing bigger and generating lots of thyroid hormones independently of TSH.

A high yield fact is that In about 60% of the cases, this happens due to mutations in the TSH receptors that inappropriately keeps these follicular cells active.

On histology, this appears as focal patches of hyperfunctioning cells with a lot of colloid inside.

Now, nodules that produce a lot of thyroid hormones are called hot nodules because they show increased activity on radioactive iodine uptake tests. They are rarely malignant.

Another high yield concept is the Jod-Basedow phenomenon, or iodine-induced thyrotoxicosis.

The Jod-Basedow phenomenon is hyperthyroidism that happens shortly after administering iodine, even in the form of iodine IV contrast.

The phenomenon does not affect people with normal thyroid function but will affect individuals that’s iodine deficient and have a goiter, or in people with Graves disease, toxic multinodular goiter, or thyroid adenomas.

The key point is that all these disorders have autonomous thyroid tissue that act independently of TSH regulation, so when there’s extra iodine, it provides more material for thyroid hormone production without negative feedback from decreased TSH.

You can think of the Jod-Basedow phenomenon as the opposite of the Wolff-Chaikoff effect where a large increase in iodine actually leads to temporary decrease in thyroid hormone synthesis.

Regardless of cause, symptoms of hyperthyroidism are similar and remember that with hyperthyroidism, everything goes faster.

Metabolic findings include include heat intolerance, weight loss, and increased sweating, due to increased basal metabolic rate.

Sources
  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Thyrotropin Isoforms: Implications for Thyrotropin Analysis and Clinical Practice" Thyroid (2014)
  4. "The Clinical Significance of Subclinical Thyroid Dysfunction" Endocrine Reviews (2007)
  5. "Hyperthyroidism and other Causes of Thyrotoxicosis: Management Guidelines of the American Thyroid Association and American Association of Clinical Endocrinoloigists" Endocrine Practice (2011)
  6. "Emergency Medicine: A Comprehensive Study Guide, Sixth edition" McGraw-Hill Professional (2003)
  7. "β-Adrenergic blockade for the treatment of hyperthyroidism" The American Journal of Medicine (1992)